04052912gtam personal page - To The Moon

04052912gtam

04052912gtam

No personal profile

114Follow

5Followers

0Topic

0Badge

2021-07-08

$Zomedica Pharmaceuticals Corp.(ZOM)$??????

2021-06-29

$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish

2021-05-04

Hi engsoon how r u

@Ces95:Cmonnnn

2021-05-03

Chua eng soon

Sorry, the original content has been removed

2021-04-30

Hogogogoogo

2021-04-30

$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish still

2021-04-26

$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo

2021-04-13

$Zomedica Pharmaceuticals Corp.(ZOM)$Jiayou

2021-04-10

$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish

2021-04-09

$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish

2021-04-06

Nice

2021-03-31

Let’s go!! $Zomedica Pharmaceuticals Corp.(ZOM)$

2021-03-26

Diamonds hands baby

2021-03-26

$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo!!!

2021-03-24

$Zomedica Pharmaceuticals Corp.(ZOM)$Gogogogo

2021-03-23

$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo

2021-03-22

Nice

@168HUATAH:Wow good stuff

2021-03-20

$Castor Maritime, Inc.(CTRM)$Still bullish

2021-03-19

$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish baby

2021-03-19

$Zomedica Pharmaceuticals Corp.(ZOM)$Easy hold

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3567740041252265","uuid":"3567740041252265","gmtCreate":1604646018202,"gmtModify":1758043826757,"name":"04052912gtam","pinyin":"04052912gtam","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":114,"tweetSize":71,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.20","exceedPercentage":"93.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.20","exceedPercentage":"93.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":149792019,"gmtCreate":1625747574631,"gmtModify":1703747669430,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>??????","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>??????","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$??????","images":[{"img":"https://static.tigerbbs.com/6bafb363a7b8e989705e461d19a89a87","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/149792019","isVote":1,"tweetType":1,"viewCount":1841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159925178,"gmtCreate":1624937373794,"gmtModify":1703848376727,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish","images":[{"img":"https://static.tigerbbs.com/38c60bd765cdddd9c0479df18c946028","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159925178","isVote":1,"tweetType":1,"viewCount":2826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":106673483,"gmtCreate":1620117616842,"gmtModify":1704338882992,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Hi engsoon how r u","listText":"Hi engsoon how r u","text":"Hi engsoon how r u","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/106673483","repostId":"106829406","repostType":1,"repost":{"id":106829406,"gmtCreate":1620103201605,"gmtModify":1704338699679,"author":{"id":"3578202042128081","authorId":"3578202042128081","name":"Ces95","avatar":"https://static.tigerbbs.com/a34c87c6fac521846374a81d1c309fca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578202042128081","idStr":"3578202042128081"},"themes":[],"htmlText":"Cmonnnn","listText":"Cmonnnn","text":"Cmonnnn","images":[{"img":"https://static.tigerbbs.com/612614e12124611b6c6cbf8a934c88b8","width":"1080","height":"2288"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106829406","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108542381,"gmtCreate":1620045655843,"gmtModify":1704337791989,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Chua eng soon","listText":"Chua eng soon","text":"Chua eng soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/108542381","repostId":"108555711","repostType":1,"isVote":1,"tweetType":1,"viewCount":1743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109708476,"gmtCreate":1619716309995,"gmtModify":1704271324528,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Hogogogoogo","listText":"Hogogogoogo","text":"Hogogogoogo","images":[{"img":"https://static.tigerbbs.com/20af949d08c04a78c1f0cec424e9648c","width":"750","height":"2320"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109708476","isVote":1,"tweetType":1,"viewCount":1943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":109708258,"gmtCreate":1619716228874,"gmtModify":1704271324191,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish still","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish still","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish still","images":[{"img":"https://static.tigerbbs.com/f59cb125cb4114d198a3216767bd17ad","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109708258","isVote":1,"tweetType":1,"viewCount":2337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":374202181,"gmtCreate":1619446834343,"gmtModify":1704724052238,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo","images":[{"img":"https://static.tigerbbs.com/4c18afe1b11064e3e2bcaabbcbb7c095","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374202181","isVote":1,"tweetType":1,"viewCount":1839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":345092596,"gmtCreate":1618253782915,"gmtModify":1704708191789,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Jiayou","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Jiayou","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Jiayou","images":[{"img":"https://static.tigerbbs.com/6c63cc671a1b72867519b10721f12cfa","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/345092596","isVote":1,"tweetType":1,"viewCount":2266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":346333216,"gmtCreate":1617988219235,"gmtModify":1704705746137,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish","images":[{"img":"https://static.tigerbbs.com/b59e794dd58d4bba9e12381360b0a449","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/346333216","isVote":1,"tweetType":1,"viewCount":2603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":348894070,"gmtCreate":1617901648790,"gmtModify":1704704652587,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish","images":[{"img":"https://static.tigerbbs.com/d76dd721d23ab327d3b7af121e9b194a","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348894070","isVote":1,"tweetType":1,"viewCount":1898,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":343609508,"gmtCreate":1617709094704,"gmtModify":1704702038641,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[{"img":"https://static.tigerbbs.com/f52296816920f7b5770c08cfc64cef5e","width":"1125","height":"1974"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/343609508","isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":354592482,"gmtCreate":1617185048946,"gmtModify":1704696927969,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Let’s go!! <a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","listText":"Let’s go!! <a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","text":"Let’s go!! $Zomedica Pharmaceuticals Corp.(ZOM)$","images":[{"img":"https://static.tigerbbs.com/6fcdb21b982c01c72b70a2b11ef73134","width":"750","height":"2364"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/354592482","isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":358771523,"gmtCreate":1616735925962,"gmtModify":1704798080927,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Diamonds hands baby","listText":"Diamonds hands baby","text":"Diamonds hands baby","images":[{"img":"https://static.tigerbbs.com/adde6da7906010348e9ea840d5449c9f","width":"750","height":"2484"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/358771523","isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":358297771,"gmtCreate":1616691796393,"gmtModify":1704797574374,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo!!!","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo!!!","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo!!!","images":[{"img":"https://static.tigerbbs.com/949d9d08c395a16ef033cf8083e377ec","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/358297771","isVote":1,"tweetType":1,"viewCount":437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":351906414,"gmtCreate":1616549998038,"gmtModify":1704795521427,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogogogo","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogogogo","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Gogogogo","images":[{"img":"https://static.tigerbbs.com/6d06e7fb1a972e6e6d10c8dfeb8dfd70","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351906414","isVote":1,"tweetType":1,"viewCount":587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":353274132,"gmtCreate":1616505973226,"gmtModify":1704794979173,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Gogo","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Gogo","images":[{"img":"https://static.tigerbbs.com/c9f7dd0ca92e09b2f4f8387775814457","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/353274132","isVote":1,"tweetType":1,"viewCount":611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":359730659,"gmtCreate":1616423037471,"gmtModify":1704793938605,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359730659","repostId":"359480415","repostType":1,"repost":{"id":359480415,"gmtCreate":1616420199537,"gmtModify":1704793830977,"author":{"id":"3576310036676699","authorId":"3576310036676699","name":"168HUATAH","avatar":"https://static.tigerbbs.com/f1b0a44d689dc6261632c04707767859","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576310036676699","idStr":"3576310036676699"},"themes":[],"htmlText":"Wow good stuff&nbsp;","listText":"Wow good stuff&nbsp;","text":"Wow good stuff","images":[{"img":"https://static.tigerbbs.com/8ed150c9b66422a80401e6545e79ec49","width":"1125","height":"2620"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/359480415","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":350568976,"gmtCreate":1616232665595,"gmtModify":1704792370896,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>Still bullish","listText":"<a href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a>Still bullish","text":"$Castor Maritime, Inc.(CTRM)$Still bullish","images":[{"img":"https://static.tigerbbs.com/922aad0ca4e45f4a181909b404d5e49c","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/350568976","isVote":1,"tweetType":1,"viewCount":603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":350994578,"gmtCreate":1616146678394,"gmtModify":1704791519039,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish baby","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish baby","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish baby","images":[{"img":"https://static.tigerbbs.com/00e492e26c850418f775cf5552841f89","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/350994578","isVote":1,"tweetType":1,"viewCount":1296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":327200266,"gmtCreate":1616083401455,"gmtModify":1704790833129,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Easy hold","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Easy hold","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Easy hold","images":[{"img":"https://static.tigerbbs.com/6ef2ca2f468c09f3b848e785e777a4cc","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327200266","isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":329341514,"gmtCreate":1615212262338,"gmtModify":1704779614768,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go!!!!","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go!!!!","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Let’s go!!!!","images":[{"img":"https://static.tigerbbs.com/5c437afbdd25a99b03fc13590f196384","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/329341514","isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321381694,"gmtCreate":1615394326618,"gmtModify":1704782255278,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Let’s go","images":[{"img":"https://static.tigerbbs.com/f7927b0ad56a637f2387bdb5d5278c04","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321381694","isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":346333216,"gmtCreate":1617988219235,"gmtModify":1704705746137,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Bullish","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Bullish","images":[{"img":"https://static.tigerbbs.com/b59e794dd58d4bba9e12381360b0a449","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/346333216","isVote":1,"tweetType":1,"viewCount":2603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159925178,"gmtCreate":1624937373794,"gmtModify":1703848376727,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish","images":[{"img":"https://static.tigerbbs.com/38c60bd765cdddd9c0479df18c946028","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159925178","isVote":1,"tweetType":1,"viewCount":2826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":350994578,"gmtCreate":1616146678394,"gmtModify":1704791519039,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish baby","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Still bullish baby","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Still bullish baby","images":[{"img":"https://static.tigerbbs.com/00e492e26c850418f775cf5552841f89","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/350994578","isVote":1,"tweetType":1,"viewCount":1296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328567653,"gmtCreate":1615541660372,"gmtModify":1704784314199,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Ez hold baby","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Ez hold baby","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Ez hold baby","images":[{"img":"https://static.tigerbbs.com/c0bcbfb7a07c3d32347dd31fdb407b6d","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/328567653","isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321848019,"gmtCreate":1615424449231,"gmtModify":1704782566880,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Hmmmm","listText":"Hmmmm","text":"Hmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321848019","repostId":"2118605748","repostType":4,"isVote":1,"tweetType":1,"viewCount":543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362937258,"gmtCreate":1614585825474,"gmtModify":1704772696037,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Nice nice&nbsp;","listText":"Nice nice&nbsp;","text":"Nice nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/362937258","repostId":"1176148015","repostType":4,"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321383744,"gmtCreate":1615394297788,"gmtModify":1704782254137,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Nice nice&nbsp;","listText":"Nice nice&nbsp;","text":"Nice nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/321383744","repostId":"2118672048","repostType":4,"isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3575389267348419","authorId":"3575389267348419","name":"Kokodelei","avatar":"https://static.tigerbbs.com/c315350b00e6158a875330dc1dac1396","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3575389267348419","idStr":"3575389267348419"},"content":"Can reply my comment? :)","text":"Can reply my comment? :)","html":"Can reply my comment? :)"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362937535,"gmtCreate":1614585838227,"gmtModify":1704772695874,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"&nbsp;Nice nice&nbsp;","listText":"&nbsp;Nice nice&nbsp;","text":"Nice nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/362937535","repostId":"1161169607","repostType":4,"repost":{"id":"1161169607","kind":"news","pubTimestamp":1614584947,"share":"https://ttm.financial/m/news/1161169607?lang=en_US&edition=fundamental","pubTime":"2021-03-01 15:49","market":"us","language":"en","title":"Which Companies Are Most At Risk From Surging Yields: Goldman Answers","url":"https://stock-news.laohu8.com/highlight/detail?id=1161169607","media":"zerohedge","summary":"For those living under a rock in 2021, the big story in the past month is that 10-year Treasury yiel","content":"<p>For those living under a rock in 2021, the big story in the past month is that 10-year Treasury yield have climbed by 50 bps in a month to 1.5% (technically as high as 1.61% for a few brief seconds on Thursday after the catastrophic 7Y auction triggered stop loss selling) as real rates jumped following a steady increase in inflation expectations (breakevens), which however are largely set by 10Y TIPS whose price is determined largely by the Fed due to its massive ongoing monetization of TIPS (thus crushing any actual signaling power TIPS may have). Whatever the cause, while rising breakeven inflation has driven most of the rise in yields during the past six months, the last two weeks have been characterized by a 40 bp jump in real yields.</p>\n<p><img src=\"https://static.tigerbbs.com/efd3fa48c3856c9963ae7e9f6e6de625\" tg-width=\"500\" tg-height=\"232\">It's this sudden spike in real yields as opposed to breakevens, that has sparked much of the fear in markets in the past week, because as Goldman's David Kostin explains in his Sunday Start note, \"conceptually, and historically, equities digest rising inflation expectations more easily than rising real yields\" and not just rising real yields, but a rapid spike the likes of which were last observed during the taper tantrum as we discussed two weeks ago in \"Yields Soar, Sending 30Y Real Rates Positive Amid Overheating Panic: What Happens Next\"). In any case, as a result of the violent moves in the rates complex, it is hardly a surprise that Kostin writes \"<b>the recent backup in rates has sparked a new wave of client concern.\"</b></p>\n<ul>\n <li><b>First, investors ask whether the level of rates is becoming a threat to equity valuations.</b></li>\n</ul>\n<p>Predictably,<i><b>Goldman's answer is an emphatic \"no\"</b></i>with Kostin claiming (with a straight face) that \"although the S&amp;P 500 forward P/E multiple of 22x currently ranks in the 99th historical percentile since 1976, ranking only behind the peak of the Tech Bubble in 2000, our dividend discount model (DDM) implies an equity risk premium (ERP) that ranks in the 28th percentile, 70 bp above the historical average.\" In other words, massively, record stretched PE multiples won't collapse if rates rise. Yeah, right. May want to Timestamp that David. We'll check back in a few weeks. So what<i><b>would</b></i>cause a market crash according to Goldman's head market cheerleader? Well, according to Kostin, \"<b>keeping the current P/E constant, the 10-year yield would have to reach 2.1% to bring the yield gap to the historical median of 250 bp.If instead the yield gap remains unchanged, and rates rise to 2.0%, then the P/E multiple would fall by 10% to 20x.\"</b>But don't worry, Kostin adds, because \"in today’s economic environment, our macro model suggests the ERP should be narrower than average.\" Translation: yes, a 10% drop is coming but our models say it may not come, so just keep buying.</p>\n<p><img src=\"https://static.tigerbbs.com/4cdbd39d9b2a4e20ee8ef423435a57d7\" tg-width=\"500\" tg-height=\"169\"></p>\n<ul>\n <li><b>Second, Goldman's bullish US equity view has already embedded expectations of rising interest rates.</b></li>\n</ul>\n<p>Addressing the second most regular pushback against its bizarre optimism, Goldman says that an environment of accelerating economic growth (and recall that recently Goldman found that theUS Economy is Growing At the Fastest Pace On Record), and higher bond yields is consistent with the bank's forecast that<b>S&amp;P 500 EPS in 2021 will grow by 27% and be 10% higher than pre-pandemic 2019, driving a 14% rise this year to our year-end price target of 4300 despite a flat P/E multiple.</b>In other words, multiples may indeed contract but the rise in earnings - a result of economic growth - will offset much if not all of the move. Furthermore, the forward market implies that 10-year nominal yields will climb 25 bp further to 1.7% - below Goldman's 2.1% redline - and real yields will climb by a similar amount to from -0.7% to -0.4% by year-end.</p>\n<ul>\n <li><b>Third, even Kostin is forced to concede that the recent change in yields has reached a magnitude that is usually a headwind for stocks.</b></li>\n</ul>\n<p>As the Goldman strategist concedes, equities have generated an average return of nearly +1% per month,<b>but the return has averaged -1% during months when nominal rates rose by more than two standard deviations and -5% when real yields rose by that amount.</b>Today, a two standard deviation monthly rise in 10-year rates equates to 40 bp for nominal yields and 30 bp for real yields, both thresholds exceeded this week.</p>\n<p><img src=\"https://static.tigerbbs.com/a6a23015dc5dbaee1d4660e8e902a000\" tg-width=\"500\" tg-height=\"175\">Of course, it's not just absolute levels across risk that are impacted by rates: Kostin also notes that \"shifting interest rates have major implications for<i><b>rotations within the equity market,</b></i>a dynamic made clear in recent weeks.\" In mid-2020, Kostin's equity valuation model showed that equity duration –the expectations of earnings growth far in the future –had become a more important contributor to multiples than ever before. One key reason for the importance that investors ascribed to expected future growth was the extremely low level of interest rates. As rates have risen, the contribution of equity duration to stock valuations has declined while near-term growth profiles have become more important. Practically,<b>this means that both the improving growth outlook and rising rates have supported the outperformance of cyclicals and value stocks relative to stocks with the highest long-term growth.</b>Hardly surprising, in recent weeks Goldman's S&amp;P 500 Growth factor has declined by 9%, similar to the 12% decline around the announcement of Pfizer-BioNTech vaccine efficacy in November</p>\n<p>Which brings us to the one sector most at risk from the continued risk in yields.</p>\n<p>As Kostin writes, \"<b>this rotation has also weighed on one of the most spectacular outperformers of the last 12 months: Stocks with negative earnings but strong expected growth.\"</b>One of the most remarkable moves of the past year is that<b>a basket of non-profitable tech stocks soared by 204% last year and 27% in the first six weeks of 2021... before falling by 15% in last two weeks.</b>The decline of these high-growth firms has been particularly painful given the current record degree of leverage carried by hedge funds and the elevated activity of retail traders, both of whom have recently favored some of these long-duration stocks.</p>\n<p>To be sure, while earnings for S&amp;P 500 firms declined by 13% in 2020, the fall in aggregate profits does not capture the wide dispersion in operating results that occurred inside the market. While 2020 EPS growth was negative for the overall index and the median stock,<b>the actual level of profits was positive... But not for every company.</b>In fact,<b>1082 firms or 37% of the constituents in the Russell 3000 posted negative net income in 2020 (i.e., a loss or negative EPS), and 21% posted negative EBITDA.</b></p>\n<p>Getting even more granular (and apologizing to George Orwell), Kostin then notes that all companies with losses are equal, but some are more equal than others. Some firms reported negative earnings in 2020 because the pandemic and economic shutdown disrupted their business and crushed their revenues.<b>But in other instances, the Goldman strategist points out that \"companies grew sales so rapidly that top-line was the focus of investors and bottom-line losses were ignored.\"</b>Indeed, consider that across all non-Financial US stocks with at least $50 million in revenues, \"<b>those with negative earnings and declining revenues in 2020 returned a median of -18% last year. In contrast, stocks with negative earnings and growing revenues returned +51%.\"</b></p>\n<p><img src=\"https://static.tigerbbs.com/672e0f0b03d6b3cec8ec067276919bf9\" tg-width=\"500\" tg-height=\"171\"><b>Recently, however, improving economic growth prospects from vaccination rollout and pending fiscal stimulus coupled with rising rates have moved firms that struggled most in 2020 into pole position so far in 2021.</b>The cyclical and virus-affected firms with<b>negative earnings and falling sales in 2020 have generated a median YTD return of +22%, outperforming the +10% return of the median stock that posted a loss but grew sales last year.</b>Unsurprisingly, these cyclical stocks have been positively correlated with both nominal and real interest rates. In contrast,<b>the ultra long-duration stocks have been negatively correlated with interest rates given they generate no earnings today and their valuations depend entirely on future growth prospects.</b>Cyclicals also carry far lower valuations, with a median EV/2022 sales ratio of 2x vs. 6x for the median negative earner with positive sales growth.</p>\n<p><img src=\"https://static.tigerbbs.com/a00a42075ac35763072cb85546315087\" tg-width=\"500\" tg-height=\"174\">Putting it all together, Kostin concludes that \"<b>looking forward, investors must balance the appeal of promising businesses with the risk that rates rise further and the recent rotation continues.\"</b>The list of non-profitable companies that makes up GOldman's Non-Profitable Tech basket is shown below:</p>\n<p><img src=\"https://static.tigerbbs.com/782b2dbfc010259d8bc5120f85d13070\" tg-width=\"500\" tg-height=\"364\">And although secular growth stocks may remain the most appealing investments on a long-term horizon, Goldman believes that<b>those stocks will underperform more cyclical firms in the short-term if economic acceleration and inflation continue to lift interest rates.</b></p>\n<p>Which brings us to the other side of the table: the<b>chart below shows the Russell 1000 firms from each sector with the shortest implied equity durations that have outperformed sector peers during the past two weeks as rates rose and are expected to grow revenues in 2021</b>. The median stock trades at a P/E ratio of 19x and has returned 7% YTD compared with 22x and 2% for the Russell 1000 median.</p>\n<p><img src=\"https://static.tigerbbs.com/96e14fcedd553203d06c6a3639a17f8f\" tg-width=\"500\" tg-height=\"365\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Which Companies Are Most At Risk From Surging Yields: Goldman Answers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhich Companies Are Most At Risk From Surging Yields: Goldman Answers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-01 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/which-companies-are-most-risk-surging-yields-goldman-answers?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For those living under a rock in 2021, the big story in the past month is that 10-year Treasury yield have climbed by 50 bps in a month to 1.5% (technically as high as 1.61% for a few brief seconds on...</p>\n\n<a href=\"https://www.zerohedge.com/markets/which-companies-are-most-risk-surging-yields-goldman-answers?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯"},"source_url":"https://www.zerohedge.com/markets/which-companies-are-most-risk-surging-yields-goldman-answers?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161169607","content_text":"For those living under a rock in 2021, the big story in the past month is that 10-year Treasury yield have climbed by 50 bps in a month to 1.5% (technically as high as 1.61% for a few brief seconds on Thursday after the catastrophic 7Y auction triggered stop loss selling) as real rates jumped following a steady increase in inflation expectations (breakevens), which however are largely set by 10Y TIPS whose price is determined largely by the Fed due to its massive ongoing monetization of TIPS (thus crushing any actual signaling power TIPS may have). Whatever the cause, while rising breakeven inflation has driven most of the rise in yields during the past six months, the last two weeks have been characterized by a 40 bp jump in real yields.\nIt's this sudden spike in real yields as opposed to breakevens, that has sparked much of the fear in markets in the past week, because as Goldman's David Kostin explains in his Sunday Start note, \"conceptually, and historically, equities digest rising inflation expectations more easily than rising real yields\" and not just rising real yields, but a rapid spike the likes of which were last observed during the taper tantrum as we discussed two weeks ago in \"Yields Soar, Sending 30Y Real Rates Positive Amid Overheating Panic: What Happens Next\"). In any case, as a result of the violent moves in the rates complex, it is hardly a surprise that Kostin writes \"the recent backup in rates has sparked a new wave of client concern.\"\n\nFirst, investors ask whether the level of rates is becoming a threat to equity valuations.\n\nPredictably,Goldman's answer is an emphatic \"no\"with Kostin claiming (with a straight face) that \"although the S&P 500 forward P/E multiple of 22x currently ranks in the 99th historical percentile since 1976, ranking only behind the peak of the Tech Bubble in 2000, our dividend discount model (DDM) implies an equity risk premium (ERP) that ranks in the 28th percentile, 70 bp above the historical average.\" In other words, massively, record stretched PE multiples won't collapse if rates rise. Yeah, right. May want to Timestamp that David. We'll check back in a few weeks. So whatwouldcause a market crash according to Goldman's head market cheerleader? Well, according to Kostin, \"keeping the current P/E constant, the 10-year yield would have to reach 2.1% to bring the yield gap to the historical median of 250 bp.If instead the yield gap remains unchanged, and rates rise to 2.0%, then the P/E multiple would fall by 10% to 20x.\"But don't worry, Kostin adds, because \"in today’s economic environment, our macro model suggests the ERP should be narrower than average.\" Translation: yes, a 10% drop is coming but our models say it may not come, so just keep buying.\n\n\nSecond, Goldman's bullish US equity view has already embedded expectations of rising interest rates.\n\nAddressing the second most regular pushback against its bizarre optimism, Goldman says that an environment of accelerating economic growth (and recall that recently Goldman found that theUS Economy is Growing At the Fastest Pace On Record), and higher bond yields is consistent with the bank's forecast thatS&P 500 EPS in 2021 will grow by 27% and be 10% higher than pre-pandemic 2019, driving a 14% rise this year to our year-end price target of 4300 despite a flat P/E multiple.In other words, multiples may indeed contract but the rise in earnings - a result of economic growth - will offset much if not all of the move. Furthermore, the forward market implies that 10-year nominal yields will climb 25 bp further to 1.7% - below Goldman's 2.1% redline - and real yields will climb by a similar amount to from -0.7% to -0.4% by year-end.\n\nThird, even Kostin is forced to concede that the recent change in yields has reached a magnitude that is usually a headwind for stocks.\n\nAs the Goldman strategist concedes, equities have generated an average return of nearly +1% per month,but the return has averaged -1% during months when nominal rates rose by more than two standard deviations and -5% when real yields rose by that amount.Today, a two standard deviation monthly rise in 10-year rates equates to 40 bp for nominal yields and 30 bp for real yields, both thresholds exceeded this week.\nOf course, it's not just absolute levels across risk that are impacted by rates: Kostin also notes that \"shifting interest rates have major implications forrotations within the equity market,a dynamic made clear in recent weeks.\" In mid-2020, Kostin's equity valuation model showed that equity duration –the expectations of earnings growth far in the future –had become a more important contributor to multiples than ever before. One key reason for the importance that investors ascribed to expected future growth was the extremely low level of interest rates. As rates have risen, the contribution of equity duration to stock valuations has declined while near-term growth profiles have become more important. Practically,this means that both the improving growth outlook and rising rates have supported the outperformance of cyclicals and value stocks relative to stocks with the highest long-term growth.Hardly surprising, in recent weeks Goldman's S&P 500 Growth factor has declined by 9%, similar to the 12% decline around the announcement of Pfizer-BioNTech vaccine efficacy in November\nWhich brings us to the one sector most at risk from the continued risk in yields.\nAs Kostin writes, \"this rotation has also weighed on one of the most spectacular outperformers of the last 12 months: Stocks with negative earnings but strong expected growth.\"One of the most remarkable moves of the past year is thata basket of non-profitable tech stocks soared by 204% last year and 27% in the first six weeks of 2021... before falling by 15% in last two weeks.The decline of these high-growth firms has been particularly painful given the current record degree of leverage carried by hedge funds and the elevated activity of retail traders, both of whom have recently favored some of these long-duration stocks.\nTo be sure, while earnings for S&P 500 firms declined by 13% in 2020, the fall in aggregate profits does not capture the wide dispersion in operating results that occurred inside the market. While 2020 EPS growth was negative for the overall index and the median stock,the actual level of profits was positive... But not for every company.In fact,1082 firms or 37% of the constituents in the Russell 3000 posted negative net income in 2020 (i.e., a loss or negative EPS), and 21% posted negative EBITDA.\nGetting even more granular (and apologizing to George Orwell), Kostin then notes that all companies with losses are equal, but some are more equal than others. Some firms reported negative earnings in 2020 because the pandemic and economic shutdown disrupted their business and crushed their revenues.But in other instances, the Goldman strategist points out that \"companies grew sales so rapidly that top-line was the focus of investors and bottom-line losses were ignored.\"Indeed, consider that across all non-Financial US stocks with at least $50 million in revenues, \"those with negative earnings and declining revenues in 2020 returned a median of -18% last year. In contrast, stocks with negative earnings and growing revenues returned +51%.\"\nRecently, however, improving economic growth prospects from vaccination rollout and pending fiscal stimulus coupled with rising rates have moved firms that struggled most in 2020 into pole position so far in 2021.The cyclical and virus-affected firms withnegative earnings and falling sales in 2020 have generated a median YTD return of +22%, outperforming the +10% return of the median stock that posted a loss but grew sales last year.Unsurprisingly, these cyclical stocks have been positively correlated with both nominal and real interest rates. In contrast,the ultra long-duration stocks have been negatively correlated with interest rates given they generate no earnings today and their valuations depend entirely on future growth prospects.Cyclicals also carry far lower valuations, with a median EV/2022 sales ratio of 2x vs. 6x for the median negative earner with positive sales growth.\nPutting it all together, Kostin concludes that \"looking forward, investors must balance the appeal of promising businesses with the risk that rates rise further and the recent rotation continues.\"The list of non-profitable companies that makes up GOldman's Non-Profitable Tech basket is shown below:\nAnd although secular growth stocks may remain the most appealing investments on a long-term horizon, Goldman believes thatthose stocks will underperform more cyclical firms in the short-term if economic acceleration and inflation continue to lift interest rates.\nWhich brings us to the other side of the table: thechart below shows the Russell 1000 firms from each sector with the shortest implied equity durations that have outperformed sector peers during the past two weeks as rates rose and are expected to grow revenues in 2021. The median stock trades at a P/E ratio of 19x and has returned 7% YTD compared with 22x and 2% for the Russell 1000 median.","news_type":1,"symbols_score_info":{".DJI":0.9,"SPY":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360997782,"gmtCreate":1613806388846,"gmtModify":1704885247034,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PULM\">$Pulmatrix(PULM)$</a>relax&nbsp;guys","listText":"<a href=\"https://laohu8.com/S/PULM\">$Pulmatrix(PULM)$</a>relax&nbsp;guys","text":"$Pulmatrix(PULM)$relax guys","images":[{"img":"https://static.tigerbbs.com/d3ad5aec1993aa1f8f262596915861a8","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/360997782","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574922039374018","authorId":"3574922039374018","name":"没买没上","avatar":"https://static.tigerbbs.com/a52a4d12771281e9f76fc32b8ad847db","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3574922039374018","idStr":"3574922039374018"},"content":"Ok lets huat at $3","text":"Ok lets huat at $3","html":"Ok lets huat at $3"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":149792019,"gmtCreate":1625747574631,"gmtModify":1703747669430,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>??????","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>??????","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$??????","images":[{"img":"https://static.tigerbbs.com/6bafb363a7b8e989705e461d19a89a87","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/149792019","isVote":1,"tweetType":1,"viewCount":1841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":354592482,"gmtCreate":1617185048946,"gmtModify":1704696927969,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Let’s go!! <a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","listText":"Let’s go!! <a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","text":"Let’s go!! $Zomedica Pharmaceuticals Corp.(ZOM)$","images":[{"img":"https://static.tigerbbs.com/6fcdb21b982c01c72b70a2b11ef73134","width":"750","height":"2364"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/354592482","isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":321841303,"gmtCreate":1615424426102,"gmtModify":1704782565741,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321841303","repostId":"2118460618","repostType":4,"repost":{"id":"2118460618","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615423210,"share":"https://ttm.financial/m/news/2118460618?lang=en_US&edition=fundamental","pubTime":"2021-03-11 08:40","market":"us","language":"en","title":"EV startup Canoo plans to roll out American-built, pod-like electric pickup in 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2118460618","media":"Reuters","summary":"DETROIT, March 10  - Electric vehicle startup Canoo Inc on Wednesday said it will introduce an American-built pod-like electric pickup truck in 2023, following in the footsteps of several rivals also entering the most popular segment of the U.S. automotive market.Canoo Executive Chairman Tony Aquila revealed the timing for the truck ahead of an Automobility LA event on Thursday. He said the Los Angeles-based company would begin taking pre-orders in the second quarter of 2021.Aquila told Reuters ","content":"<p>DETROIT, March 10 (Reuters) - Electric vehicle startup Canoo Inc on Wednesday said it will introduce an American-built pod-like electric pickup truck in 2023, following in the footsteps of several rivals also entering the most popular segment of the U.S. automotive market.</p>\n<p>Canoo Executive Chairman Tony Aquila revealed the timing for the truck ahead of an Automobility LA event on Thursday. He said the Los Angeles-based company would begin taking pre-orders in the second quarter of 2021.</p>\n<p>Aquila told Reuters he was aiming to launch the rounded, snub-nosed truck in the first quarter of 2023, and Canoo will build the vehicle in a U.S. microfactory it intends to open.</p>\n<p>\"This is like no truck you've ever seen,\" he said in an interview. \"It's the size of a Ford Ranger, can take the payload of a full-sized pickup and (has) the turning radius of a Prius.\"</p>\n<p>Aquila told Reuters in December that Canoo, which subsequently went public through a reverse merger with a special purpose acquisition company, intended to introduce a pickup.</p>\n<p>Pickups are the top-selling vehicles in the U.S. new-vehicle market, with Ford Motor Co , General Motors Co and <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a>'s Ram brand dominating the gasoline-powered segment and generating large portions of those companies' profits.</p>\n<p>While GM and Ford plan to introduce electric pickups with the intention of continuing their dominance, Canoo, Tesla</p>\n<p>with its Cybertruck, and others believe they can carve out a piece of the market as EV sales increase.</p>\n<p>GM, Tesla, and startups Rivian and Lordstown Motors Corp&nbsp;all plan to introduce electric pickups later this year, with Ford following in mid-2022.</p>\n<p>Forecasting firm AutoForecast Solutions estimates electric pickups will make up just over 1% of North American pickup production in 2022, rising to 5.7% in 2028.</p>\n<p>Canoo's pickup will join a lineup that includes the pod-like, seven-seat canoo coming in the second quarter of 2022, a delivery vehicle later that year and a sport sedan in 2025.</p>\n<p>The pickup will be aimed at both consumer and commercial customers and has the potential to be a high-volume vehicle, creating the need for a small-scale, highly automated microfactory, Aquila said.</p>\n<p>Canoo is negotiating with states about a potential site and the company will still use a contract manufacturer to build its lower-volume vehicles, he said.</p>\n<p>Canoo has developed a \"skateboard\" - a low-rise platform that bundles batteries and electric motors with such chassis components as steering, brakes and wheels - on which a variety of vehicle body types can be built.</p>\n<p>Canoo said its pickup will have up to 600 horsepower and an electric driving range of more than 200 miles (320 km). Aquila expects the driving range to be 300 miles or higher by the time the truck actually launches.</p>\n<p>The pickup includes a six-foot (2m) truck bed that can extend to a fully enclosed eight feet. It also features front cargo storage area and a fold-down worktable with electrical outlets, flip-down side tables and a hidden step offering storage and access to the truck bed.</p>\n<p>(Reporting by Ben Klayman in Detroit Editing by Chris Reese and Lincoln Feast)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV startup Canoo plans to roll out American-built, pod-like electric pickup in 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV startup Canoo plans to roll out American-built, pod-like electric pickup in 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-11 08:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DETROIT, March 10 (Reuters) - Electric vehicle startup Canoo Inc on Wednesday said it will introduce an American-built pod-like electric pickup truck in 2023, following in the footsteps of several rivals also entering the most popular segment of the U.S. automotive market.</p>\n<p>Canoo Executive Chairman Tony Aquila revealed the timing for the truck ahead of an Automobility LA event on Thursday. He said the Los Angeles-based company would begin taking pre-orders in the second quarter of 2021.</p>\n<p>Aquila told Reuters he was aiming to launch the rounded, snub-nosed truck in the first quarter of 2023, and Canoo will build the vehicle in a U.S. microfactory it intends to open.</p>\n<p>\"This is like no truck you've ever seen,\" he said in an interview. \"It's the size of a Ford Ranger, can take the payload of a full-sized pickup and (has) the turning radius of a Prius.\"</p>\n<p>Aquila told Reuters in December that Canoo, which subsequently went public through a reverse merger with a special purpose acquisition company, intended to introduce a pickup.</p>\n<p>Pickups are the top-selling vehicles in the U.S. new-vehicle market, with Ford Motor Co , General Motors Co and <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a>'s Ram brand dominating the gasoline-powered segment and generating large portions of those companies' profits.</p>\n<p>While GM and Ford plan to introduce electric pickups with the intention of continuing their dominance, Canoo, Tesla</p>\n<p>with its Cybertruck, and others believe they can carve out a piece of the market as EV sales increase.</p>\n<p>GM, Tesla, and startups Rivian and Lordstown Motors Corp&nbsp;all plan to introduce electric pickups later this year, with Ford following in mid-2022.</p>\n<p>Forecasting firm AutoForecast Solutions estimates electric pickups will make up just over 1% of North American pickup production in 2022, rising to 5.7% in 2028.</p>\n<p>Canoo's pickup will join a lineup that includes the pod-like, seven-seat canoo coming in the second quarter of 2022, a delivery vehicle later that year and a sport sedan in 2025.</p>\n<p>The pickup will be aimed at both consumer and commercial customers and has the potential to be a high-volume vehicle, creating the need for a small-scale, highly automated microfactory, Aquila said.</p>\n<p>Canoo is negotiating with states about a potential site and the company will still use a contract manufacturer to build its lower-volume vehicles, he said.</p>\n<p>Canoo has developed a \"skateboard\" - a low-rise platform that bundles batteries and electric motors with such chassis components as steering, brakes and wheels - on which a variety of vehicle body types can be built.</p>\n<p>Canoo said its pickup will have up to 600 horsepower and an electric driving range of more than 200 miles (320 km). Aquila expects the driving range to be 300 miles or higher by the time the truck actually launches.</p>\n<p>The pickup includes a six-foot (2m) truck bed that can extend to a fully enclosed eight feet. It also features front cargo storage area and a fold-down worktable with electrical outlets, flip-down side tables and a hidden step offering storage and access to the truck bed.</p>\n<p>(Reporting by Ben Klayman in Detroit Editing by Chris Reese and Lincoln Feast)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118460618","content_text":"DETROIT, March 10 (Reuters) - Electric vehicle startup Canoo Inc on Wednesday said it will introduce an American-built pod-like electric pickup truck in 2023, following in the footsteps of several rivals also entering the most popular segment of the U.S. automotive market.\nCanoo Executive Chairman Tony Aquila revealed the timing for the truck ahead of an Automobility LA event on Thursday. He said the Los Angeles-based company would begin taking pre-orders in the second quarter of 2021.\nAquila told Reuters he was aiming to launch the rounded, snub-nosed truck in the first quarter of 2023, and Canoo will build the vehicle in a U.S. microfactory it intends to open.\n\"This is like no truck you've ever seen,\" he said in an interview. \"It's the size of a Ford Ranger, can take the payload of a full-sized pickup and (has) the turning radius of a Prius.\"\nAquila told Reuters in December that Canoo, which subsequently went public through a reverse merger with a special purpose acquisition company, intended to introduce a pickup.\nPickups are the top-selling vehicles in the U.S. new-vehicle market, with Ford Motor Co , General Motors Co and Stellantis NV's Ram brand dominating the gasoline-powered segment and generating large portions of those companies' profits.\nWhile GM and Ford plan to introduce electric pickups with the intention of continuing their dominance, Canoo, Tesla\nwith its Cybertruck, and others believe they can carve out a piece of the market as EV sales increase.\nGM, Tesla, and startups Rivian and Lordstown Motors Corp all plan to introduce electric pickups later this year, with Ford following in mid-2022.\nForecasting firm AutoForecast Solutions estimates electric pickups will make up just over 1% of North American pickup production in 2022, rising to 5.7% in 2028.\nCanoo's pickup will join a lineup that includes the pod-like, seven-seat canoo coming in the second quarter of 2022, a delivery vehicle later that year and a sport sedan in 2025.\nThe pickup will be aimed at both consumer and commercial customers and has the potential to be a high-volume vehicle, creating the need for a small-scale, highly automated microfactory, Aquila said.\nCanoo is negotiating with states about a potential site and the company will still use a contract manufacturer to build its lower-volume vehicles, he said.\nCanoo has developed a \"skateboard\" - a low-rise platform that bundles batteries and electric motors with such chassis components as steering, brakes and wheels - on which a variety of vehicle body types can be built.\nCanoo said its pickup will have up to 600 horsepower and an electric driving range of more than 200 miles (320 km). Aquila expects the driving range to be 300 miles or higher by the time the truck actually launches.\nThe pickup includes a six-foot (2m) truck bed that can extend to a fully enclosed eight feet. It also features front cargo storage area and a fold-down worktable with electrical outlets, flip-down side tables and a hidden step offering storage and access to the truck bed.\n(Reporting by Ben Klayman in Detroit Editing by Chris Reese and Lincoln Feast)","news_type":1,"symbols_score_info":{"GOEV":0.9,"F":0.9,"GM":0.9}},"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362541078,"gmtCreate":1614652159294,"gmtModify":1704773551325,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>gonna go to the moon guys don’t miss out","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>gonna go to the moon guys don’t miss out","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$gonna go to the moon guys don’t miss out","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/362541078","isVote":1,"tweetType":1,"viewCount":1136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366575367,"gmtCreate":1614525360959,"gmtModify":1704772251646,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Oh man","listText":"Oh man","text":"Oh man","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/366575367","repostId":"1117820997","repostType":4,"isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":369093323,"gmtCreate":1613986124162,"gmtModify":1704886467817,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PULM\">$Pulmatrix(PULM)$</a>Buy buy","listText":"<a href=\"https://laohu8.com/S/PULM\">$Pulmatrix(PULM)$</a>Buy buy","text":"$Pulmatrix(PULM)$Buy buy","images":[{"img":"https://static.tigerbbs.com/bd961b6650ec8c9eeca1b7ae901deee4","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/369093323","isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":361622345,"gmtCreate":1614230581887,"gmtModify":1704889912644,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Let’s go","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Let’s go","images":[{"img":"https://static.tigerbbs.com/3590737503e7aa307741130bdb81b54a","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/361622345","isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328520997,"gmtCreate":1615541695719,"gmtModify":1704784314684,"author":{"id":"3567740041252265","authorId":"3567740041252265","name":"04052912gtam","avatar":"https://community-static.tradeup.com/news/592216963422b4b61e96a65be11d6419","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567740041252265","idStr":"3567740041252265"},"themes":[],"htmlText":"Runner soon","listText":"Runner soon","text":"Runner soon","images":[{"img":"https://static.tigerbbs.com/174c3d089a90768b04a024ee4778baad","width":"750","height":"2424"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/328520997","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}